z-logo
open-access-imgOpen Access
Down-Regulation of miR-3928 Promoted Osteosarcoma Growth
Author(s) -
Haidong Xu,
Xiaozhou Liu,
Jianning Zhao
Publication year - 2014
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000358718
Subject(s) - cancer research , osteosarcoma , cell cycle , cyclin dependent kinase 6 , microrna , cell growth , erbb3 , biology , transfection , cancer , cell cycle checkpoint , medicine , cyclin d1 , gene , genetics , epidermal growth factor receptor
Osteosarcoma is the most common primary bone malignancy in children and young adults. Most failures of osteosarcoma treatment were due to resistance to chemotherapy. Development of new therapy required elucidation underlying molecular mechanism. Many miRNAs have been proved to be involved in the pathogenesis of osteosarcoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom